Novel Structurally Varied N-Alkyl 1,4-Dihydropyridines as ABCB1 Inhibitors: Structure-Activity Relationships, Biological Activity and First Bioanalytical Evaluation

Author(s): Andreas Hilgeroth, Christiane Baumert, Claudius Coburger, Marianne Seifert, Soren Krawczyk, Cornelius Hempel, Felix Neubauer, Martin Krug, Josef Molnar, Hermann Lage

Journal Name: Medicinal Chemistry

Volume 9 , Issue 4 , 2013

Become EABM
Become Reviewer


Series of structurally varied N-alkyl 1,4-dihydropyridines and novel benzo-annelated derivatives as 1,4- dihydroquinolines have been characterized as ABCB1 inhibitors. Structure-activity relationships (SARs) are discussed. Cytotoxic activities of selected compounds have been determined. A first bioanalysis of ABCB1 substrate properties has been carried out in a cell-based model. Compounds with highest ABCB1 inhibiting activities were no substrates of ABCB1 and not transported by the efflux pump, thus profiling the new ABCB1 inhibitors.

Keywords: ABCB1 inhibitor, structure-activity relationships, ABCB1 substrate properties

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [487 - 493]
Pages: 7
DOI: 10.2174/1573406411309040002
Price: $65

Article Metrics

PDF: 14